Frovatriptan (Frova®) is a triptan drug developed by Endo Pharmaceuticals for the treatment of migraine headaches. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head. It is available as 2.5 mg tablets.

Frovatriptan has mean terminal elimination half-life of approximately 26 hours, which is substantially longer than for other triptans.

Frovatriptan is available only by prescription in the United States.

External links

• Frova (manufacturer's website)
• Frovatriptan (patient information)

Triptans

Frovatriptan